Thc Biomed Intl(OTC) THCBF

Market CapN/A

Since IPO (2015)-100%

5 Year-100%

1 Year+0%

1 Month+0%

$0.00

+0.00%

+0.00Today

Thc Biomed Intl last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-08-14

Thc Biomed Intl stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-08-06
1 month	+0%	USD 0.00	2026-06-12
3 month	+0%	USD 0.00	2026-05-14
Year to date	+0%	USD 0.00	2025-12-30
1 year	+0%	USD 0.00	2025-08-13
3 year	-100%	USD 0.02	2023-08-15
5 year	-100%	USD 0.08	2021-08-13
Since inception	-100%	USD 0.05	2015-08-31

Thc Biomed Intl Financials at a Glance

Market Cap

N/A

Revenue (TTM)

CA$2.86M

Net Income (TTM)

-CA$3.67M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

271.17 (High)

Dividend

$0.00

Beta (Volatility)

271.17 (High)

Price

$0.00

Volume

Open

$0.00

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Jul 3, 2026

Dividend

$0.00

Beta (Volatility)

271.17 (High)

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Jul 3, 2026

THCBF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Thc Biomed Intl

THC Biomed Intl Ltd. is a Canadian company focused on the production and sale of cannabis products for medical and recreational use. Established in 2012, the company operates from Kelowna, Canada, offering a diverse range of cannabis-infused edibles and drinks.

Products and Services

Cannabis-infused beverages, including shots and drinks
Edibles such as gummies and biscuits under the THC KISS label
Standalone pure cannabis sticks for consumers

Growth Outlook

Recent quarterly revenue of CAD 476,230 shows potential for recovery
Inventory levels indicate a strong product pipeline with CAD 2,547,638 in stock
Market demand for cannabis products continues to grow, supporting future sales

Financial Highlights

Trailing twelve months (TTM) revenue of CAD 2,938,000 reflects market presence
Net income for the latest quarter was CAD -935,212, indicating ongoing challenges
Current ratio of 0.63 suggests liquidity management is a focus area

THC Biomed Intl Ltd. operates in the rapidly evolving cannabis industry, which has seen significant growth in recent years. The company's diverse product offerings cater to both medical and recreational consumers, positioning it well within the market. Despite facing financial challenges, recent revenue trends and inventory levels suggest potential for recovery and growth. The ongoing demand for cannabis products provides a favorable backdrop for future sales, making THC Biomed an intriguing option for investors interested in the cannabis sector.

AI Generated • Jul 30, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

John Miller

Website

www.thcbiomed.com

Headquarters

Kelowna, BC V1Y9H2, CA

THCBF Financials

Key Financial Metrics (TTM)

Gross Margin

-30.83%

Operating Margin

-95.89%

Net Income Margin

-91.79%

Return on Equity

-36.68%

Return on Capital

-30.50%

Return on Assets

-20.79%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

Avg. Volume

349.968

Financials (TTM)

Gross Profit

-CA$1.16M

Operating Income

-CA$3.05M

EBITDA

-CA$2.03M

Operating Cash Flow

-CA$503.46K

Capital Expenditure

-CA$232.15K

Free Cash Flow

-CA$735.61K

Cash & ST Invst.

CA$205.02K

Total Debt

CA$2.59M

Thc Biomed Intl Performance Analysis

Thc Biomed Intl annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-07-31	CAD 2,631,673	N/A

Thc Biomed Intl sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2022-07-31	28.4%
Q1	2022-10-31	-25.6%
Q2	2023-01-31	22.3%
Q3	2023-04-30	-41.7%

Thc Biomed Intl annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-07-31	CAD -0.01	N/A

Thc Biomed Intl sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2022-07-31	-975.0%
Q1	2022-10-31	76.7%
Q2	2023-01-31	-205.0%
Q3	2023-04-30	6.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2023YOY CHG

Revenue

CA$476.23K

-31.9%

Gross Profit

-CA$370.40K

-84.5%

Gross Margin

-77.78%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-CA$935.21K

-613.3%

EBITDA

-CA$585.40K

-402.1%

Quarterly Fundamentals

Name

Q3 2023YOY CHG

Total Cash

CA$205.02K

-82.3%

Total Debt

CA$2.59M

-14.0%

Accounts Receivable

CA$109.11K

-76.4%

Inventory

CA$2.55M

-22.3%

Long Term Debt

CA$975.26K

-49.4%

Short Term Debt

CA$1.61M

+49.1%

Return on Assets

-20.79%

N/A

Return on Invested Capital

-40.53%

N/A

Free Cash Flow

CA$38.56K

+106.0%

Operating Cash Flow

CA$38.91K

+108.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AVTBFAvant Brands Inc.

AVTBFAvant Brands Inc.$0.44-4.14%

BBRRFBlueberries Medical Corp.

BBRRFBlueberries Medical Corp.$0.01+34.62%

PCLOFPharmaCielo Ltd.

PCLOFPharmaCielo Ltd.$0.05+47.06%

CANNTrees Corporation

CANNTrees Corporation$0.02+15.26%

MVMDFMountain Valley MD Holdings Inc.

MVMDFMountain Valley MD Holdings Inc.$0.04-22.53%

RVVQFRavenQuest BioMed Inc.

RVVQFRavenQuest BioMed Inc.$0.00+0.00%

BUDZWEED, Inc.

BUDZWEED, Inc.$0.03+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NUNu Holdings

NUNu Holdings$15.23+0.09%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$8.76+0.01%

ONDSOndas

ONDSOndas$9.24+0.04%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$140.00-0.01%

INTCIntel

INTCIntel$102.50-0.02%

NVDANvidia

NVDANvidia$225.16-0.00%

NOKNokia

NOKNokia$10.76+0.02%

Questions About THCBF

What is the current price of Thc Biomed Intl?

Thc Biomed Intl is trading at $0.00 per share.

What is the 52-week range for Thc Biomed Intl?

Over the past 52 weeks, Thc Biomed Intl has traded between $0.00 and $0.00.

How much debt does Thc Biomed Intl have?

As of the most recent reporting period, Thc Biomed Intl reported total debt of CA$3.50M.

How much cash does Thc Biomed Intl have on hand?

Thc Biomed Intl reported CA$377.79K in cash and cash equivalents in its most recent financial results.

What is Thc Biomed Intl’s dividend yield?

Thc Biomed Intl does not currently have a dividend yield.

Thc Biomed Intl(OTC) THCBF

Thc Biomed Intl Financials at a Glance

THCBF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Thc Biomed Intl

THCBF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Thc Biomed Intl Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About THCBF

What is the current price of Thc Biomed Intl?

What is the 52-week range for Thc Biomed Intl?

How much debt does Thc Biomed Intl have?

How much cash does Thc Biomed Intl have on hand?

What is Thc Biomed Intl’s dividend yield?

Premium Investing Services